Challenges and opportunities in combating viral hepatitis in India: insights from the Indian Hepatitis Summit 2025
Vivekanandan Shanmugam, John Ward, Sujatha Vijayakumar, Giten Khwairakpam, Cary James, Lokesh Shanmugam, Vaishnavi Girija, Bharat Bhushan Rewari

TL;DR
The Indian Hepatitis Summit 2025 brought together experts to address challenges in combating viral hepatitis in India and promote collaborative solutions.
Contribution
The summit provided insights into current challenges and opportunities for eliminating viral hepatitis in India through collaborative efforts and innovative tools like the Hepat App.
Findings
The summit identified barriers to hepatitis elimination and discussed potential solutions.
The Hepat App and a Hepatitis Online Course were launched to improve public health outcomes.
Discussions highlighted the importance of screening, diagnosis, treatment, and reducing stigma associated with viral hepatitis.
Abstract
The world has committed to ending viral hepatitis as a public health threat as part of sustainable development goal 3.3. World Health Organization (WHO) has developed Global Health Sector Strategies (GHSS 2022–2030) to provide guidance to countries to end viral hepatitis by 2030. India instituted the national program for prevention and control of viral hepatitis (National Viral Hepatitis Control Program, NVHCP) in 2018 in alignment with the global perspective and strategic framework. The Chennai Liver Foundation conducted the first Indian Hepatitis Summit 2025 as a collective movement towards a hepatitis-free India. The summit was conducted on January 17–18, 2025, at Chennai. Healthcare professionals, policymakers, advocates, researchers, and civil society representatives gathered to share successes, discuss barriers, and address the urgent challenges of viral hepatitis and promote…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHepatitis B Virus Studies · Hepatitis C virus research · Hepatitis Viruses Studies and Epidemiology
